Södertälje, Sweden

Sven Hellberg


 

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 38(Granted Patents)


Location History:

  • Södertälje, SE (2006 - 2008)
  • Sodertalje, SE (2009 - 2010)

Company Filing History:


Years Active: 2006-2010

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Sven Hellberg: Innovator in Pharmaceutical Chemistry

Introduction

Sven Hellberg is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target critical biological pathways.

Latest Patents

Hellberg holds 10 patents that showcase his innovative work. His latest patents include the development of 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3). These compounds, defined by specific formulas, are processed for their preparation and include new intermediates used in their synthesis. Additionally, he has developed selective phenyl substituted aminopyrazine inhibitors of GSK-3, which are useful for the prevention and treatment of cognitive disorders.

Career Highlights

Sven Hellberg is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on innovative therapeutic solutions that address significant health challenges.

Collaborations

Throughout his career, Hellberg has collaborated with esteemed colleagues such as Stefan Berg and Ratan Bhat. These partnerships have contributed to the advancement of his research and the successful development of new pharmaceutical compounds.

Conclusion

Sven Hellberg's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a key inventor in the field. His work continues to impact the development of therapies for cognitive disorders and other health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…